Is MAP1A p.Arg2009Gln (c.6026G>A) pathogenic?

MAP1A p.Arg2009Gln (c.6026G>A) is classified Uncertain significance in MAP1A (ClinVar, Single submitter, 1 submitter; last evaluated 2024-08-12). AlphaMissense: likely benign (0.0767); Ultra-rare (popmax 0.0565%, nfe).

How common is MAP1A p.Arg2009Gln (c.6026G>A) in the general population?

MAP1A p.Arg2009Gln (c.6026G>A) is ultra-rare (popmax 0.0565%, nfe) (gnomAD).

What do computational predictors say about MAP1A p.Arg2009Gln (c.6026G>A)?

AlphaMissense predicts likely benign (score 0.0767) — an in-silico prediction, not a clinical call.

MAP1A p.Arg2009Gln

c.6026G>A · rs199600508 · VCV2353786

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.0767 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0565%, nfe)

Missense predictors

0/2 damaging

AlphaMissense, REVEL · SaProt no call

Computational evidence

Protein change
AlphaMissense	0.0767	likely benign
REVEL	0.038	moderately benign-leaning
SaProt	—	not scored · why
⇒ AlphaMissense and REVEL both call this tolerated; SaProt makes no call.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 0.65	GERP 0.66, phastCons 0.064
Overall
CADD	14.43	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0565% European (non-Finnish) · 667/1,180,010 alleles

Filtering AF 0.053% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0515%

Overall 0.0462% 745/1,613,958 alleles · ultra-rare exomes 698/1,461,818 · genomes 47/152,140 · joint denominator

Ancestry group	Frequency	1 in
European (non-Finnish)grpmax	0.0565%	1,769
Remaining individualsnot grpmax-eligible	0.0544%	1,838
Finnishnot grpmax-eligible	0.0313%	3,199
Admixed American	0.0233%	4,286
African / African-American	0.0134%	7,490

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: MAP1A
Protein: p.Arg2009Gln
Coding: c.6026G>A
MANE Select: NM_002373
dbSNP: rs199600508
Type: single nucleotide variant
Location: chr15:43527499 (GRCh38)
Structure: AlphaFold pLDDT 94.44 · 41 PDB

Full MAP1A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

MAP1A p.Arg2734Gln Uncertain significance ★★ same type
MAP1A p.Gly567Ala Uncertain significance ★★ ⚠ same type
MAP1A p.Gly482= Benign/Likely benign ★★ same type
MAP1A p.Leu1621Val Benign ★★ same type
MAP1A p.Ser1152= Likely benign ★★ same type
MAP1A p.Ser1311= Benign/Likely benign ★★ same type
MAP1A p.Ser1544= Benign ★★ same type
MAP1A p.Ser1858Cys Likely benign ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/map1a-p-arg2009gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown